Enhancement of bioavailability and anthelmintic efficacy of albendazole by solid dispersion and cyclodextrin complexation techniques

Pharmazie

Volumn 62, Issue 8, 2007, Pages 604-607

  Kalaiselvan, R ^a,b   Mohanta, G P ^a   Madhusudan, S ^a   Manna, P K ^a   Manavalan, R ^a  

^a ANNAMALAI UNIVERSITY   (India)

^b RANBAXY RESEARCH LABORATORIES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ALBENDAZOLE; ALBENDAZOLE SULFOXIDE; CYCLODEXTRIN; POVIDONE; TARTARIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHELMINTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DISPERSION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG FORMULATION; HELMINTHIASIS; MALE; MOUSE; NONHUMAN; RABBIT; SINGLE DRUG DOSE; STOMACH PH; TRICHINELLA SPIRALIS;

ALBENDAZOLE; ANIMALS; ANTHELMINTICS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CYCLODEXTRINS; DATA INTERPRETATION, STATISTICAL; EXCIPIENTS; GASTRIC ACIDITY DETERMINATION; HYDROGEN-ION CONCENTRATION; RABBITS; TRICHINELLA SPIRALIS;

EID: 34548268168     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2007.8.6274     Document Type: Article

References (22)

1. Amidon GL, Lennernas H, Shah VP, Crison JR (1995) A theoretical basis of biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12: 413-420.
2. Anonymous (1995) Cerebral cysticercosis: what can be expected of cysticidal drugs?. WHO Drug Inf 9: 134-138.
3. Castillo JA, Palomo-Canales J, Garcia JJ, Lastres JL, Bolas F, Torrado JJ (1999) Preparation and characterization of albendazole β-cyclodextrin complexes. Drug Dev Ind Pharm 25: 1241-1248.
4. Delatour P, Benoit E, Besse S (1991) Comparative enantioselectivity in the sulphoxidation of albendazole in man, dogs and rats. Xenobiotica 21: 217-221.
5. Denham D, Martinez AR (1970) Studies with methyridine and Trichinella spiralis. The use of the drugs to study the rate of larval production in mice. J Helminthol 44: 357-363.
6. del Estal JL, Alvarez AI, Villaverde C, Justel A, Prieto JG (1994) Increased systemic bioavailability of albendazol when administered with surfactants in rats. Int J Pharm 102: 257-260.
7. Forbes LB, Gajadhar AA (1999) A validated Trichinella digestion assay and an associated sampling and quality assurance system for use in testing pork and horsemeat. J Food Prot 62: 1308-1313.
8. Jung H, Hurtado M, Sanchez M, Medina MY, Sotelo J (1992) Clinical pharmacokinetics of albendazole in patients with brain cysticercosis. J Clin Pharmacol 32: 28-31.
9. Jung H, Medina L, Garcia L, Fuentes I, Esparza RM (1998) Absorption studies of albendazole and some physicochemical properties of the drug and its metabolite, albendazole sulphoxide. J Pharm Pharmacol 50: 43-48.
10. Kalaiselvan R, Mohanta GP, Manna PK, Manavalan R (2006a) Inhibition of albendazole crystallization in poly(vinylpyrrolidone) solid molecular dispersions. Pharmazie 61: 618-624.
11. Kalaiselvan R, Mohanta GP, Manna PK, Manavalan R (2006b) Multicomponent system of albendazole with cyclodextrins and hydroxyacids. Acta Pharm Sci 48: 19-33.
12. Kalaiselvan R, Mohanta GP, Manna PK, Manimekalai A (2006c) Solid-phase preparation and characterization of albendazole solid dispersion. ARS Pharm 47: 91-107.
13. Keramidas D, Mavridis G, Soutis M, Passalidis A (2004) Medical treatment of pulmonary hydatidosis: complications and surgical management. Pediatr Surg Int 19: 774-776.
14. Kohri N, Yamayoshi Y, Iseki K, Sato N, Todo S, Miyazaki K (1998) Effect of gastric pH on the bioavailability of albendazole. Pharm Pharmacol Commun 4: 267-270.
15. Kohri N, Yamayoshi Y, Xin H, Iseki K, Sato N, Todo S, Miyazaki K (1999) Improving the oral bioavailability of albendazole in rabbits by the solid dispersion technique. J Pharm Pharmacol 51: 159-164.
16. Kumar A, Chattopadhyay TK (1992) Management of hydatid disease of liver. Postgrad Med J 68: 853-856.
17. Liu M, Boireau P (2002) Trichinellosis in China: epidemiology and control. Trends Parasitol 18: 553-556.
18. Lopez-Garcia ML, Torrado S, Torrado S, Martinez AR, Bolas F (1998) Methimazole mediated enhancement of oral bioavailability and anthelmintic effects against parenteral stages of Trichinella spiralis in mice: The influence of the dose regime. Vet Parasitol 75: 209-219.
19. Mallick S, Sahoo A, Mitra SS (2003) Preparation, physicochemical characterization and drug release studies of albendazole solid dispersions. Boll Chim Farm 142: 180-186.
20. Mura P, Faucci MT (2001) Multicomponent system of econazole with hydroxyacids and cyclodextrins. J Incl Phenom Macro 39: 131-138.
21. Rigter IM, Schipper HG, Koopmans RP, Kan MV, Frijlink HW, Kager PA, Guchelaar HJ (2004) Relative bioavailability of three newly developed albendazole formulations, a randomized crossover study with healthy volunteers. Antimicrob Agents Chemother 48: 1051-1054.
22. Torrado S, Torrado S, Torrado JJ, Cadorniga R (1996) Preparation, dissolution and characterization of albendazole solid dispersions. Int J Pharm 140: 247-250.